The post WBTC Whale Sells 9,516.8 ETH in Flash-Loan Circular Loan, Aave Debt Drops to $121M but Health Factor 1.12 Signals Looming Liquidation Risk appeared on BitcoinEthereumNews.com. COINOTAG reported on November 19 that on‑chain analyst Yu Jin tracks a whale deploying a flash loan–based circular loan strategy to unwind leverage. The entity trimmed risk by selling 9,516.8 ETH to repay 29.36 million USDT, at an average price near $3,085 per ETH. On Aave, the borrowed exposure fell from $150 million to about $121 million, while the position’s health factor rose from 1.04 to 1.12—still below a safety threshold and not deemed fully secure. The remaining collateral comprises 1,560 WBTC (roughly $144 million) and 9,000 ETH (about $28.04 million). If BTC and ETH continue to slide, the whale may need further liquidations to pare down the exposure. Investors should monitor the health factor, Aave debt, and the evolving WBTC/ETH collateral balance for risk signals. Source: https://en.coinotag.com/breakingnews/wbtc-whale-sells-9516-8-eth-in-flash-loan-circular-loan-aave-debt-drops-to-121m-but-health-factor-1-12-signals-looming-liquidation-riskThe post WBTC Whale Sells 9,516.8 ETH in Flash-Loan Circular Loan, Aave Debt Drops to $121M but Health Factor 1.12 Signals Looming Liquidation Risk appeared on BitcoinEthereumNews.com. COINOTAG reported on November 19 that on‑chain analyst Yu Jin tracks a whale deploying a flash loan–based circular loan strategy to unwind leverage. The entity trimmed risk by selling 9,516.8 ETH to repay 29.36 million USDT, at an average price near $3,085 per ETH. On Aave, the borrowed exposure fell from $150 million to about $121 million, while the position’s health factor rose from 1.04 to 1.12—still below a safety threshold and not deemed fully secure. The remaining collateral comprises 1,560 WBTC (roughly $144 million) and 9,000 ETH (about $28.04 million). If BTC and ETH continue to slide, the whale may need further liquidations to pare down the exposure. Investors should monitor the health factor, Aave debt, and the evolving WBTC/ETH collateral balance for risk signals. Source: https://en.coinotag.com/breakingnews/wbtc-whale-sells-9516-8-eth-in-flash-loan-circular-loan-aave-debt-drops-to-121m-but-health-factor-1-12-signals-looming-liquidation-risk

WBTC Whale Sells 9,516.8 ETH in Flash-Loan Circular Loan, Aave Debt Drops to $121M but Health Factor 1.12 Signals Looming Liquidation Risk

COINOTAG reported on November 19 that on‑chain analyst Yu Jin tracks a whale deploying a flash loan–based circular loan strategy to unwind leverage. The entity trimmed risk by selling 9,516.8 ETH to repay 29.36 million USDT, at an average price near $3,085 per ETH. On Aave, the borrowed exposure fell from $150 million to about $121 million, while the position’s health factor rose from 1.04 to 1.12—still below a safety threshold and not deemed fully secure. The remaining collateral comprises 1,560 WBTC (roughly $144 million) and 9,000 ETH (about $28.04 million). If BTC and ETH continue to slide, the whale may need further liquidations to pare down the exposure. Investors should monitor the health factor, Aave debt, and the evolving WBTC/ETH collateral balance for risk signals.

Source: https://en.coinotag.com/breakingnews/wbtc-whale-sells-9516-8-eth-in-flash-loan-circular-loan-aave-debt-drops-to-121m-but-health-factor-1-12-signals-looming-liquidation-risk

Market Opportunity
Wrapped BTC Logo
Wrapped BTC Price(WBTC)
$94,931.88
$94,931.88$94,931.88
+0.60%
USD
Wrapped BTC (WBTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.